Thursday, April 14, 2011

Emami announces acquisition of exclusive India rights of ‘Multi Plant Stem cell’

<> <>

The company has acquired the exclusive India rights of the proven, tried and tested technology from Mibelle Biochemistry of Switzerland.

The Rs. 1100 cr. Emami Limited makers of Boroplus, Fair and Handsome, Zandu Balm and Navratna has announced the acquisition of the exclusive India rights of a phenomenal award winning skin care technology – ‘Multi Plant Stem cell’ which will change the dynamics of the skin care industry in the country and pave the way for a new course of growth for Emami. The company has acquired the exclusive India rights of the proven, tried and tested technology from Mibelle Biochemistry of Switzerland.
The breakthrough Multi Plant Stem cell technology has won several international accolades which include the innovation prize for the best active ingredient at the European Cosmetics Awards. This technology is utilized by the likes of top international names such as 3 Lab,  Absolute Precious Cells, Skinvage, Lancome and many other brands. 
The current Indian skin care market is valued at Rs. 5000 crores approx (Source: AC Nielsen, MAT DEC 2010) growing at the rate of 15 %.  The “Multi Plant Stem Cells” can be used in any skin care products. With the “Multi Plant Stem Cells” Emami will have a cutting edge technology in terms of product offering which is unique as currently no player is offering this in India. The company will have the exclusive use of this technology in the country. This tie up will highlight the international expertise that Emami brings to India for its consumers

ANIMA SINHA
PGDM - 2sem

No comments:

Post a Comment